Compound details
2-O-(5,8,11,14,17-Eicosapentaenoyl)-1-O-hexadecylglycero-3-phosphocholine
| Compound ID | CDAMM01138 |
|---|---|
| Common name | 2-O-(5,8,11,14,17-Eicosapentaenoyl)-1-O-hexadecylglycero-3-phosphocholine | IUPAC name | (3-hexadecoxy-2-icosa-5,8,11,14,17-pentaenoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate |
| Molecular formula | C44H80NO7P |
| Retention time | 17.56 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 766.577 | Theoretical mz | 766.574 |
| Error | 3.68 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.8947 |
| Inchi key | YHSSHPWVFALMBA-UCKGYWORNA-N |
|---|---|
| Smiles | O=C(OC(COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C)CCCC=CCC=CCC=CCC=CCC=CCC |
| Superclass | Lipids and lipid-like molecules |
| Class | Glycerophospholipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SEA |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SEA |
| O00206 | TLR4 | Toll-like receptor 4 (by homology) | T81443 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| Q8TDS5 | OXER1 | Oxoeicosanoid receptor 1 | T68834 | SEA |
| Q9HBW0 | LPAR2 | Lysophosphatidic acid receptor Edg-4 | T39380 | SEA |
| P43657 | LPAR6 | Lysophosphatidic acid receptor 6 | T13484 | SEA |
| Q9H1C0 | LPAR5 | Lysophosphatidic acid receptor 5 | T18616 | SEA |
| Q9UPC5 | GPR34 | Probable G-protein coupled receptor 34 | T73859 | SEA |
| O00398 | P2RY10 | Putative P2Y purinoceptor 10 | T00488 | SEA |
| Q9BXC1 | GPR174 | Probable G-protein coupled receptor 174 | T87661 | SEA |
| Q9UBY5 | LPAR3 | Lysophosphatidic acid receptor Edg-7 | T95923 | SEA |
| Q92633 | LPAR1 | Lysophosphatidic acid receptor Edg-2 | T92640 | SEA |
| P16885 | PLCG2 | Phospholipase C-gamma-2 | T93922 | SEA |
| Q99677 | LPAR4 | Lysophosphatidic acid receptor 4 | T58130 | SEA |
| Q9UP65 | PLA2G4C | Cytosolic phospholipase A2 gamma | T91113 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T81443 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | O00206 | TLR4 |
| T81443 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O00206 | TLR4 |
| T81443 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | O00206 | TLR4 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T95923 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9UBY5 | LPAR3 |
| T95923 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q9UBY5 | LPAR3 |
| T92640 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q92633 | LPAR1 |
| T92640 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q92633 | LPAR1 |
| T92640 | DI0351 | Psoriasis | [ICD-11: EA90] | Q92633 | LPAR1 |
| T92640 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q92633 | LPAR1 |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |